High Density Lipoprotein (HDL) Cholesterol: Leveraging Practice-Based Biobank Cohorts to Characterize Clinical and Genetic Predictors of Treatment Outcome

Por Wilke, Russell A.
Publicado em 2010

SLCO1B1 Genotyping for Statins (Point-Counterpoint)

Por Wilke, Russell A., Fanciullo, Joseph
Publicado no S D Med (2017)

Mapping Genes that Predict Treatment Outcome in Admixed Populations

Por Baye, Tesfaye M., Wilke, Russell A.
Publicado em 2010

Genetics and Variable Drug Response

Por Wilke, Russell A., Dolan, M. Eileen
Publicado em 2011

CYP2C19 genotype-guided antiplatelet therapy: promises and pitfalls

Por Ellithi, Moataz, Baye, Jordan, Wilke, Russell A
Publicado no Pharmacogenomics (2020)

Genomic and geographic distribution of private SNPs and pathways in human populations

Por Baye, Tesfaye M, Wilke, Russell A, Olivier, Michael
Publicado em 2009

Genotype–environment interactions and their translational implications

Por Baye, Tesfaye M, Abebe, Tilahun, Wilke, Russell A
Publicado em 2011

Individualized risk for statin-induced myopathy: Current knowledge, emerging challenges, and potential solutions

Por Feng, QiPing, Wilke, Russell A., Baye, Tesfaye M.
Publicado em 2012

Pharmacogenomics: The genetics of variable drug responses

Por Roden, Dan M., Wilke, Russell A., Kroemer, Heyo K., Stein, C. Michael
Publicado em 2011

Chronic Kidney Disease in Agricultural Communities

Por Wilke, Russell A., Qamar, Mohammad, Lupu, Roxana A., Gu, Shaopeng, Zhao, Jing
Publicado no Am J Med (2019)

Pharmacogenetics of ophthalmic topical β-blockers

Por Sidjanin, Duska J, McCarty, Catherine A, Patchett, Richard, Smith, Edward, Wilke, Russell A
Publicado em 2008

Lack of Association Between Polymorphisms in the Prostaglandin F(2α) Receptor (PTGFR) and Solute Carrier Organic Anion Transporter Family 2A1 (SLCO2A1) Genes and Intraocular Pressu...

Por McCarty, Catherine A., Berg, Richard, Patchett, Richard, Wilke, Russell A., Burmester, James K.
Publicado em 2011

PharmGKB Summary: Very Important Pharmacogene Information for RYR1

Por Alvarellos, Maria L., Krauss, Ronald M., Wilke, Russell A., Altman, Russ B., Klein, Teri E.
Publicado no Pharmacogenet Genomics (2016)

K(+) channel modulation in rodent neurohypophysial nerve terminals by sigma receptors and not by dopamine receptors

Por Wilke, Russell A, Lupardus, Patrick J, Grandy, David K, Rubinstein, Marcelo, Low, Malcolm J, Jackson, Meyer B
Publicado em 1999

Impact of Age, CYP2C9 Genotype and Concomitant Medication on the Rate of Rise for Prothrombin Time During the First 30 Days of Warfarin Therapy

Por Wilke, Russell A., Berg, Richard L., Vidaillet, Humberto J., Caldwell, Michael D., Burmester, James K., Hillman, Michael A.
Publicado em 2005

Membrane-delimited coupling between sigma receptors and K(+) channels in rat neurohypophysial terminals requires neither G-protein nor ATP

Por Lupardus, Patrick J, Wilke, Russell A, Aydar, Ebru, Palmer, Chris P, Chen, Yuenmu, Ruoho, Arnold E, Jackson, Meyer B
Publicado em 2000

Cardiovascular Pharmacogenomics

Por Roden, Dan M., Johnson, Julie A., Kimmel, Steven, Krauss, Ronald M., Medina, Marisa Wong, Shuldiner, Alan, Wilke, Russell A.
Publicado em 2011

Use of an Electronic Medical Record for the Identification of Research Subjects with Diabetes Mellitus

Por Wilke, Russell A., Berg, Richard L., Peissig, Peggy, Kitchner, Terrie, Sijercic, Bozana, McCarty, Catherine A., McCarty, Daniel J.
Publicado em 2007

Quantification of the clinical modifiers impacting high density lipoprotein (HDL) cholesterol in the community: Personalized Medicine Research Project (PMRP)

Por Wilke, Russell A., Berg, Richard L., Linneman, James G., Peissig, Peggy, Starren, Justin, Ritchie, Marilyn D., McCarty, Catherine A.
Publicado no Prev Cardiol (2010)

CNR1 Genotype Influences HDL-Cholesterol Response to Change in Dietary Fat Intake

Por Silver, Heidi J., Niswender, Kevin D., Keil, Charles D., Jiang, Lan, Feng, Qiping, Chiu, Sally, Krauss, Ronald M., Wilke, Russell A.
Publicado em 2012